Advertisement

Counseling and Management of Patients with Intracranial Atherosclerosis Disease

  • Abdul R. TarabishyEmail author
  • Maurice M. Miller
  • Ansaar T. Rai
Chapter

Abstract

Optimizing management of intracranial atherosclerosis is an evolving aspect of neurovascular care in which medical management remains the mainstay of treatment. Endovascular therapy is reserved for patients who fail best medical management with adequate control of associated risk factors and despite dual antiplatelet therapy. Primary submaximal angioplasty is a safe first-line endovascular treatment followed by stenting if necessary.

Keywords

Intracranial atherosclerosis disease Intracranial vascular imaging Antiplatelet therapy in intracranial atherosclerosis Intracranial angioplasty Mori classification of stenosis Antiplatelet therapy in intracranial atherosclerosis disease 

References

  1. 1.
    Gorelick PB, Wong KS, Bae HJ, et al. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39(8):2396–9.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1(3):158–9.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26(1):14–20.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    De Silva DA, Woon FP, Lee MP, et al. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007;38(9):2592–4.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Rincon F, Sacco RL, Kranwinkel G, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2009;28(1):65–71.  https://doi.org/10.1159/000219299.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–16.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Wong KS, Ng PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology. 2007;68(23):2035–8.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69(6):963–74.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39(9):1246–50.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Alexandrov AV, Sloan MA, Tegeler CH, et al. Practice standards for transcranial Doppler (TCD) ultrasound. Part II. Clinical indications and expected outcomes. J Neuroimaging. 2012;22(3):215–24.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Hussain AS, Hussain NS. Intravascular ultrasound for intracranial and extracranial carotid artery stent placement. Cureus. 2016;8(8):e732.  https://doi.org/10.7759/cureus.732.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Turan TN, Bonilha L, Morgan PS, et al. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2011;21(2):e159–61.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26(5):1012–21.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol. 2001;22(5):928–36.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Amin-Hanjani S, Du X, Zhao M, et al. Use of quantitative magnetic resonance angiography to stratify stroke risk in symptomatic vertebrobasilar disease. Stroke. 2005;36(6):1140–5.CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Donahue MJ, Dethrage LM, Faraco CC, et al. Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis. Stroke. 2014;45(8):2335–41.CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Dubow JS, Salamon E, Greenberg E, et al. Mechanism of acute ischemic stroke in patients with severe middle cerebral artery atherosclerotic disease. J Stroke Cerebrovasc Dis. 2014;23(5):1191–4.CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Jeon P, Kim BM, Kim DI, et al. Emergent self-expanding stent placement for acute intracranial or extracranial internal carotid artery dissection with significant hemodynamic insufficiency. AJNR Am J Neuroradiol. 2010;31(8):1529–32.CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Alexander MD, Meyers PM, English JD, et al. Symptom differences and pretreatment asymptomatic interval affect outcomes of stenting for intracranial atherosclerotic disease. AJNR Am J Neuroradiol. 2014;35(6):1157–62.CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Leng X, Wong KS, Liebeskind DS. Evaluating intracranial atherosclerosis rather than intracranial stenosis. Stroke. 2014;45(2):645–51.CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Komotar RJ, Kellner CP, Raper DM, et al. Update on the natural history of intracranial atherosclerotic disease: a critical review. World J Radiol. 2010;2(5):166–71.CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66(8):1187–91.CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: longterm prognosis. Stroke. 1982;13(6):821–4.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Huisa BN, Stemer AB, Zivin JA. Atorvastatin in stroke: a review of SPARCL and subgroup analysis. Vasc Health Risk Manag. 2010;6:229–36.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115(23):2969–75.CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366(9493):1279–89.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Lopez-Cancio E, Dorado L, Millan M, et al. The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors. Atherosclerosis. 2012;221(1):221–5.CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110(5–6):255–8.CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Herbert JM, Savi P. P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med. 2003;3(2):113–22.CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–9.CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Wong KS, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9(5):489–97.CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111(17):2233–40.CrossRefGoogle Scholar
  34. 34.
    Investigators SPS, Benavente OR, Hart RG, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367(9):817–25.CrossRefGoogle Scholar
  35. 35.
    Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331–7.CrossRefPubMedCentralGoogle Scholar
  36. 36.
    Goto S. Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl. 2005;6(4):3–11.CrossRefGoogle Scholar
  37. 37.
    Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36(4):782–6.CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Uchiyama S, Sakai N, Toi S, et al. Final results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS). Cerebrovasc Dis Extra. 2015;5(1):1–13.CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.CrossRefPubMedCentralGoogle Scholar
  40. 40.
    Investigators SS. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35(6):1388–92.CrossRefGoogle Scholar
  41. 41.
    Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–8.CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Tang CW, Chang FC, Chern CM, et al. Stenting versus medical treatment for severe symptomatic intracranial stenosis. AJNR Am J Neuroradiol. 2011;32(5):911–6.CrossRefPubMedCentralGoogle Scholar
  43. 43.
    Yu SC, Cheng HK, Cheng PW, et al. Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology. Hong Kong Med J. 2013;19(1):69–73.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Yoon W, Kim SK, Park MS, et al. Endovascular treatment and the outcomes of atherosclerotic intracranial stenosis in patients with hyperacute stroke. Neurosurgery. 2015;76(6):680–6. discussion 86.CrossRefPubMedCentralGoogle Scholar
  45. 45.
    McTaggart RA, Marks MP. The case for angioplasty in patients with symptomatic intracranial atherosclerosis. Front Neurol. 2014;5:36.  https://doi.org/10.3389/fneur.2014.00036.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30(5):1065–9.CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Nahser HC, Henkes H, Weber W, et al. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol. 2000;21(7):1293–301.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91(3):415–23.CrossRefPubMedCentralGoogle Scholar
  49. 49.
    Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19(8):1525–33.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Abdul R. Tarabishy
    • 1
    Email author
  • Maurice M. Miller
    • 2
  • Ansaar T. Rai
    • 2
  1. 1.Department of RadiologyWest Virginia UniversityMorgantownUSA
  2. 2.Department of Interventional NeuroradiologyWest Virginia UniversityMorgantownUSA

Personalised recommendations